1. Home
  2. MLTX

MLTX

MoonLake Immunotherapeutics

Logo MoonLake Immunotherapeutics

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. The company derives maximum revenue from United Kingdoms.

Founded: 2021 Country:
Switzerland
Switzerland
Employees: N/A City: ZUG
Market Cap: 2.8B IPO Year: N/A
Target Price: $75.00 AVG Volume (30 days): 483.0K
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.73 EPS Growth: N/A
52 Week Low/High: $17.82 - $64.98 Next Earning Date: 05-10-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Stock Insider Trading Activity of MoonLake Immunotherapeutics (MLTX)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Santos da Silva Jorge MLTX Chief Executive Officer Feb 27 '24 Sell $55.89 4,740 $264,918.60 2,982,814 SEC Form 4
Santos da Silva Jorge MLTX Chief Executive Officer Feb 27 '24 Sell $55.00 56,065 $3,083,575.00 2,987,554 SEC Form 4
Santos da Silva Jorge MLTX Chief Executive Officer Feb 27 '24 Sell $55.00 62,810 $3,454,550.00 3,043,619 SEC Form 4
Santos da Silva Jorge MLTX Chief Executive Officer Feb 21 '24 Sell $55.27 1,125 $62,178.75 3,106,429 SEC Form 4
Reich Kristian MLTX Chief Scientific Officer Feb 14 '24 Sell $60.15 10,000 $601,500.00 110,071 SEC Form 4
Reich Kristian MLTX Chief Scientific Officer Feb 14 '24 Sell $60.15 10,000 $601,500.00 2,997,483 SEC Form 4
Reich Kristian MLTX Chief Scientific Officer Feb 14 '24 Sell $60.16 10,000 $601,600.00 120,071 SEC Form 4
Reich Kristian MLTX Chief Scientific Officer Feb 14 '24 Sell $60.17 10,000 $601,700.00 3,007,483 SEC Form 4
Reich Kristian MLTX Chief Scientific Officer Feb 14 '24 Sell $62.43 10,000 $624,300.00 130,071 SEC Form 4
Reich Kristian MLTX Chief Scientific Officer Feb 14 '24 Sell $62.42 10,000 $624,200.00 3,017,483 SEC Form 4
Bodenstedt Matthias MLTX Chief Financial Officer Dec 19 '23 Sell $58.34 5,264 $307,101.76 520,903 SEC Form 4
Bodenstedt Matthias MLTX Chief Financial Officer Dec 19 '23 Sell $59.22 94,736 $5,610,265.92 526,167 SEC Form 4